期刊文献+

伐地那非的药效学和药代动力学 被引量:5

Pharmacodynamics and Pharmacokinetics of Vardenafil in Patients with Erectile Dysfunction
下载PDF
导出
摘要 伐地那非是一种强效、高选择性的 5型磷酸二酯酶 (PDE5 )抑制剂 ,对PDE5的抑制作用约为西地那非的 10倍。该药能显著增强阴茎勃起功能 ;而且起效迅速 ,患者口服后最早 10min即可充分勃起完成性交 ,是迄今为止起效最快的PDE5抑制剂。伐地那非口服绝对生物利用度为 15 % ,可被迅速吸收 ,血浆清除半衰期约为 4~ 5h。药效学、药代动力学、安全性及耐受性研究表明 ,伐地那非是一个治疗ED的安全、有效的口服药物。 Vardenafil is a potent and highly selective phosphodiesterase type 5 (PDE5) inhibitor with a potency about 10-fold higher than sildenafil. Vardenafil can significantly improve erectile function and works rapidly. Vardenafil is a PDE5 inhibitor with the fastest onset of action among its kind so far found and works as early as 10 minutes after oral administration, providing patients with penile erection sufficient to complete an intercourse. The absolute oral bioavailability is about 15%. Vardenafil is rapidly absorbed with a median t max of 0.7 h and a terminal half-life(t 1/2) of more than 4 h. The observed pharmacodynamic properties, pharmacokinetic characteristics and good safety and tolerability profile showed that vardenafil treatment provides an effective and generally well tolerated treatment for ED.
作者 金杰 郭应禄
出处 《中华男科学杂志》 CAS CSCD 2004年第9期711-716,共6页 National Journal of Andrology
关键词 伐地那非 勃起功能障碍 药效学 药代动力学 磷酸二酯酶5抑制剂 vardenafil erectile dysfunction pharmacodynamics pharmacokinetics phosphodiesterase type 5 inhibitor
  • 相关文献

参考文献17

  • 1Sáenz de Tejada Ⅰ, Angulo J, Cuevas P, et al. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil [J]. Int J Impot Res, 2001,13 (5): 282-290.
  • 2Kim NN, Huang YH, Goldstein Ⅰ, et al. Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by vardenafil, a novel , selective phosphodiesterase type 5 inhibitor [J]. Life Sci, 2001, 69 (19): 2249-2256.
  • 3Bischoff E, Niewohner U, Haning H, et al. The oral efficacy of vardenafil hydrochloride for inducing penile erection in a conscious rabbit model[J]. J Urol, 2001, 165 (4): 1316-1318.
  • 4Bischoff E, Schneider K. A conscious-rabbit model to study vardenafil hydrochloride and other agents that influence penile erection [J]. Int J Impot Res, 2001, 13 (4): 230-235.
  • 5Bischoff E, Mondritzki T, Niewoehner U, et al. Vardenafil improved erections in rabbits longer than expected from plasma halflife [C]. 5th Congress of the European Society for Sexual and Impotence Research, Hamburg. 2002.
  • 6Choi S, OConnell L, Min K, et al. Efficacy of vardenafil and sildenafil in facilitating penile erection in an animal model [J]. J Androl, 2002, 23 (3): 332-337.
  • 7Klotz T, Sachse R, Heidrich A, et al. Vardenafil increases pe nile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study[J]. World J Urol, 2001, 19 (1): 32-39.
  • 8Stark S, Sachse R, Liedl T, et al. Vardenafil increases penile ri gidity and tumescence in men with erectile dysfunction after a single oral dose[J]. Eur Urol, 2001,40 (2): 181-190.
  • 9Montorsi F, Padma-Nathan H, Buvat J, et al. Earliest time to onset of action leading to successful intercourse with vardenafil de termined in an at-home setting: a randomized, double-blind, pla cebo-controlled trial[J]. J Sexual Medicine, 2004, 1:164-174.
  • 10Sachse R, Rohde G, Stark S, et al. Safety, tolerability and pharmacokinetics of BAY 38-9456 in patients with erectile dysfunction [J]. J Urol, 2000,163 (suppl): 2693.

同被引文献30

  • 1金杰,贺占举,张凯,朱积川,姜辉,潘天明,庄申镕,洪铠,唐文豪,马洪铭,王晓雄,何学酉,宋涛,黄翼然,周立新,戴继灿,丁强,方杰,徐罡,蔡松良,陈军,金晓东,郭应禄.伐地那非治疗勃起功能障碍的多中心、随机、双盲、对照研究[J].中华泌尿外科杂志,2005,26(1):54-58. 被引量:5
  • 2荆志成.波生坦治疗肺动脉高压药理机制及其临床评价[J].中国医院用药评价与分析,2005,5(6):334-339. 被引量:17
  • 3洪锴,姜辉.伐地那非的安全性和耐受性[J].中华男科学杂志,2006,12(9):857-860. 被引量:2
  • 4姚方耀,刘欢,刘衡,张鹏威,阎卉,王春龙.口腔崩解片体外崩解评价方法探讨[J].中国药学杂志,2007,42(4):276-279. 被引量:33
  • 5孙传兴.临床疾病诊断依据治愈好转标准[M]第2版[M].北京:人民军医出版社,1998.41-182.
  • 6Rosen RC,Ccappelleri JC,Smith MD,et al.Development and evaluation of an abridged,5-item version of the International Index of Erectile Function(ⅡEF-5) as a diagnostic tool for erectile dysfunction[J].Int J Impot Res,1999,11 (6):319-326.
  • 7Bradley WE,Timm GW,Grallagher JM,et al.New method for continuous measurement of nocturnal penile tumescence and rigidity[J].Urology,1985,26(1):4-9.
  • 8Mckinlay JB.The worldwide prevalence and epidemiology of erectile dysfunction[J].Int J Impot Res,2000,12 (Suppl 4):S6-S11.
  • 9Seftel AD,Wilson SK,Knapp PM,et al.The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction[J].J Urol,2004,172(2):652-657.
  • 10McCullough A.Phosphodiesterase 5 inhibitors:clinicalmarket and basic science comparative studies[J].Curr Urol Rep,2004,5(6):451-459.

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部